BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 06, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Multaq dronedarone regulatory update

The European Society of Cardiology (ESC) issued guidelines for managing atrial fibrillation (AF) recommending "almost any" antiarrhythmic drug licensed for the indication, including Multaq dronedarone from sanofi-aventis, in...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >